Sarcopenia secundária: um estudo transversal em adultos hospitalizados
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Avaliar e diagnosticar a sarcopenia secundária em pacientes adultos hospitalizados. Métodos: Trata-se de estudo transversal, conduzido com 40 indivíduos, de ambos os sexos, com idade de 18 a 60 anos. Este estudo foi aprovado por Comitê de Ética em Pesquisa e os pacientes foram investigados utilizando métodos de diagnósticos de sarcopenia sugeridos pelo European Working Group on Sarcopenia in Older People (EWGSOP-2), através da utilização do questionário SARC-F, Teste de Sentar-Levantar de Cinco Vezes, medida da Circunferência da Panturrilha e Teste de Velocidade de Marcha de 4 metros para classificar a sarcopenia, além de entrevista para obtenção de dados sociodemográficos e clínicos. Resultados: A média de idade dos participantes foi de 44,65 anos, a maioria foi do sexo feminino (75%), as maiores frequências da amostra foram de hepatopatas, pneumopatas e nefropatas, onde 25% eram Provável Sarcopênico (PS), 15% foram identificados como sarcopênicos e 10% destes tinham sarcopenia grave. Conclusão: Este estudo identificou a sarcopenia em adultos hospitalizados com histórico de quedas, cuja relevância está em sinalizar para a equipe os cuidados necessários para intervir e prevenir agravos da hospitalização prolongada.
##plugins.themes.bootstrap3.article.details##
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
2. BOHANNON RW e WANG YC. Four-meter Gait Speed: Normative Values and Reliability Determined for Adults Participating in the NIH Toolbox Study. Archives of Physical Medicine and Rehabilitation, 2019; 100(3):509-513.
3. BORDA MG, et al. Sarcopenia, lung disease and mortality: a secondary analysis of the CRELES study. Geriatr Gerontol Aging, 2019; 13(1):36-8.
4. BROUESSARD C, et al. Impact of Severe Sarcopenia on Rehospitalization and Survival One Year After a TAVR Procedure in Patients Aged 75 and Older. Clin Interv Aging, 2021; 16: 1285–1292.
5. CABANAS-VALDÉS R, et al. Assessment of the 4-meter walk test test-retest reliability and concurrent validity and its correlation with the five sit-to-stand test in chronic ambulatory stroke survivors. Gait & Posture, 2023; 101:8-13.
6. CESARI M, et al. Added value of physical performance measures in predicting adverse health-related events: results from the Health, Aging And Body Composition Study. J Am Geriatr Soc, 2009; 57: 251–9.
7. CRUZ-JENTOFT AJ, et al. Sarcopenia and severity of non-alcoholic fatty liver disease. Arquivo de Gastroenterologia, 2019; 56(4):357-360.
8. CRUZ-JENTOFT AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing, 2019; 48: 16–3.
9. FURLANETTO KC, et al. Reference Values for 7 Different Protocols of Simple Functional Tests: A Multicenter Study. Archives of Physical Medicine and Rehabilitation, 2022; 103(1):20-28.e5.
10. HE N, et al. Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview. Front Cardiovasc Med. 2021; 8:743710.
11. KARPMAN C, et al. Measuring Gait Speed in the Out-Patient Clinic: Methodology and Feasibility. Respiratory Care, 2014; 59(4):531-7.
12. KELLER K e ENGELHARDT M. Strength and muscle mass loss with aging process. Age and strength loss. Muscles Ligaments Tendons J, 2014; 3(4): 346–350.
13. KO JB, et al. Predicting Sarcopenia of Female Elderly from Physical Activity Performance Measurement Using Machine Learning Classifiers. Clin Interv Aging, 2021; 16:1723-1733.
14. KRISTIANA T, et al. Association between Muscle Mass and Muscle Strength with Physical Performance in Elderly in Surabaya. Surabaya Physical Medicine and Rehabilitation Journal, 2020; 2(1), 24–34.
15. LANDI F, et al. Calf circumference, frailty and physical performance among older adults living in the community. Clin Nutr, 2014; 33: 539–44.
16. LEE HX, et al. Combined Impact of Positive Screen for Sarcopenia and Frailty on Physical Function, Cognition and Nutrition in the Community Dwelling Older Adult. Ann Geriatr Med Res, 2021; 25(3):210-216.
17. MAGGIO M, et al. Instrumental and Non-Instrumental Evaluation of 4-Meter Walking Speed in Older Individuals. PLoS ONE, 2016; 11(4):e0153583.
18. MALMSTROM T, et al. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. Journal of Cachexia, Sarcopenia and Muscle, 2016; 7(1):28-36.
19. MARTINEZ BP, et al. Massa e força muscular em idosos. Revista Brasileira de Geriatria e Gerontologia, 2016; 19(2):257-264.
20. MCLEAN RR e KIEL DP. Developing Consensus Criteria for Sarcopenia: An Update. Journal of Bone and Mineral Research, 2015; 30(4):588-92.
21. MELO TA de, et al. Teste de Sentar-Levantar Cinco Vezes: segurança e confiabilidade em pacientes idosos na alta da unidade de terapia intensiva. Rev Bras Ter Intensiva, 2019; 31(1):27-33.
22. NOLAN CM, et al. Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study. European Respiratory Journal, 2019; 53: 1801186.
23. PARRA BFCS, et al. SARC-PRO Proposta de protocolo de sarcopenia em pacientes internados. BRASPEN J, 2019; 34 (1): 58-63
24. PETERS DM, et al. Assessing the reliability and validity of a shorter walk test compared with the 10-Meter Walk Test for measurements of gait speed in healthy, older adults. J Geriatr Phys Ther., 2013; 36(1):24-30.
25. PPINIJMUNG P, et al. Prevalence and Impact of Sarcopenia in Heart Failure: A Cross-Sectional Study. The Open Cardiovascular Medicine Journal, 2022; 16 (2202240) 1874-1924.
26. RIBEIRO HS, et al. Association between sarcopenia and clinical outcomes in chronic kidney disease patients: A systematic review and meta-analysis. Clinical Nutrition, 2022; 41 (5) 1131-1140.
27. RODRIGUES F, et al. A review on aging, sarcopenia, falls and resistance training in community-dwelling elderly. Int. J. Environ. Res. Public Health, 2022; 19(2): 874.
28. SANTOS KPC, et al. Avaliação nutricional de pacientes com doença hepática crônica: comparação entre diferentes métodos. BRASPEN J, 2018; 33 (2): 170-5.
29. SOUZA IP, et al. Utilização do SARC-F para triagem de sarcopenia em pacientes adultos hospitalizados, Ntr Clín Diet Hosp., 2020; 40(3): 99-105.
30. SPATZ ES, et al. Community factors and hospital wide readmission rates: Does context matter? PLoS ONE 1. 2020; 10(0240222).
31. VAN PUYENBROECK K, et al. The Additional Value of Bioelectrical Impedance Analysis-Derived Muscle Mass as a Screening Tool in Geriatric Assessment for Fall Prevention. Gerontology, 2012; 58(5):407-12.
32. WALLMANN HW, et al. Interrater reliability of the fivetimes-sit-to-stand test. Home Health Care Manag Pract. 2012; 25(1):13-17.
33. WAN M, et al. Cellular senescence in musculoskeletal homeostasis, diseases, and regeneration. Bone Res., 2021;9(1):41.
34. WELCH C, et al. Acute Sarcopenia Secondary to Hospitalisation - An Emerging Condition Affecting Older Adults. Aging Dis., 2018; 9(1):151-164.
35. ZHANG X, et al. Falls among older adults with sarcopenia dwelling in nursing home or communCOBOity: A meta-analysis. Clin Nutr., 2020; 39(1):33-39.